Cardiac evaluation of stroke patients

Area of Science:

• Cardiology
• Neurology
• Vascular Medicine

Background:

• Patients with cerebrovascular disease face higher mortality from cardiovascular causes.
• Carotid disease patients have a significant 5-year cardiac mortality risk (40-50%).
• Cardiac evaluation serves to detect cardioembolic sources of ischemic symptoms and coexisting coronary artery disease.

Purpose of the Study:

• To evaluate the necessity and yield of cardiac testing in cerebrovascular disease patients.
• To identify patient subgroups who benefit most from cardiac evaluation.
• To improve cardiovascular prognosis in patients with cerebrovascular disease.

Main Methods:

• Review of existing clinical trials and reported series on cardiac evaluation in cerebrovascular disease.
• Analysis of cardiac testing yields in different stroke patient populations.
• Assessment of cardiovascular risk factors and mortality in patients with cerebrovascular disease.

Main Results:

• Routine cardiac testing in "usual stroke patients" without suggestive findings yields less than 10% positive results.
• Younger patients with stroke of unknown cause show greater benefit from aggressive cardiac testing.
• Patients with cerebrovascular disease, especially carotid disease, have a high prevalence of underlying cardiac ischemia, even without typical symptoms.

Conclusions:

• Cardiac evaluation is warranted in specific cerebrovascular disease patients, particularly younger individuals and those with carotid disease.
• Further research is needed to refine risk stratification and optimize cardiac testing strategies.
• Improved cardiovascular risk management is essential for patients with cerebrovascular disease.